Francis P. Crawley
-
- Ethics in Clinical Research 5
- Health and Medical Research Impacts 2
- Biotechnology and Related Fields 2
-
- Pharmacogenetics and Drug Metabolism 2
-
- Pharmacological Effects and Toxicity Studies 2
-
- Biomedical Ethics and Regulation 4
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Pharmaceutical Economics and Policy 3
- Co-authors
- David NeubauerAdamos HadjipanayisMartin WhiteŁukasz DembińskiArtur MazurPaulina NowickaDaniel WeghuberMargherita Caroli
- Journals
- SHILAP Revista de lepidopterología (1 paper)Archives of Disease in Childhood (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomSloveniaBelgium
In The Last Decade
Francis P. Crawley
15 papers receiving 103 citations
Peers
Comparison fields: 5 of 66
- Public Health, Environmental and Occupational Health 45
- Pharmacology 13
- Pharmacy 7
- Pediatrics, Perinatology and Child Health 18
- Information Systems and Management 5
Countries citing papers authored by Francis P. Crawley
This map shows the geographic impact of Francis P. Crawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis P. Crawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis P. Crawley more than expected).
Fields of papers citing papers by Francis P. Crawley
This network shows the impact of papers produced by Francis P. Crawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis P. Crawley. The network helps show where Francis P. Crawley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francis P. Crawley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 15 | |
| 6 | 2018 | 11 | |
| 7 | 2018 | 7 | |
| 8 | 2017 | 4 | |
| 9 | 2017 | 29 | |
| 10 | 2015 | 4 | |
| 11 | 2015 | 19 | |
| 12 | 2014 | 0 | |
| 13 | 2008 | 0 | |
| 14 | 2007 | 1 | |
| 15 | 2006 | 1 | |
| 16 | 2005 | 1 | |
| 17 | 2002 | 0 | |
| 18 | Universities remembering Europe. Nations, culture and Higher Education | 2000 | 1 |
| 19 | 2000 | 3 | |
| 20 | Ethics committees and informed consent: locating responsibility in clinical trials. | 1997 | 1 |
About Francis P. Crawley
Francis P. Crawley is a scholar working on Medical Laboratory Technology, Pharmacology and Public Health, Environmental and Occupational Health, having authored 25 papers that have together received 109 indexed citations. Recurring topics across this work include Ethics in Clinical Research (5 papers), Biomedical Ethics and Regulation (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Pharmaceutical Economics and Policy (3 papers), Health and Medical Research Impacts (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Biotechnology and Related Fields (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (45 citations), Pharmacology (13 citations) and Pharmacy (7 citations). Francis P. Crawley has collaborated with scholars based in United Kingdom, Slovenia and Belgium. Frequent co-authors include David Neubauer, Adamos Hadjipanayis, Martin White, Łukasz Dembiński, Artur Mazur, Paulina Nowicka, Daniel Weghuber, Margherita Caroli, Gustav Nilsonne and Brian Pickering. Their work appears in journals such as SHILAP Revista de lepidopterología, Archives of Disease in Childhood and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.